Hide Board Information

Show Board Information

W World Corp. WWHC

Board Mod: Add me as mod

Asst Mods:

Last Post: 07/02/2020 11:21:59 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

W World Corp. (OTCMRKTS: WWHC) Stock Message Board

1. WWHC Company Profile

    

2. WWHC Time & Sales

    

3. WWHC Recent News

    

4. WWHC Filings

    

5. WWHC Financials

    

6. WWHC Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

8	PARS 981% v8,7M c.106 f60,1M H.137 gap and	znewcar1	07/02/2020 11:21:59 PM
7	PARS Financials 07/16/2014 14:52:28 Pharmos Corp.	Emylers	07/16/2014 3:52:24 PM
6	Officers all done &PARS ceased 8/11/12, per	PressureWasherGuy	03/25/2014 6:31:25 AM
5	PARS 0.0841 Stock Charts $PARS 1 Month Chart	chartguy89	03/09/2014 3:53:01 AM
4	PARS Stock Charts Last: +0.0121 Friday, February	chartguy89	02/28/2014 2:55:55 PM
3	PARS Stock Charts Last: UNCH Monday, February 24,	chartguy89	02/24/2014 2:59:29 PM
2	PARS Stock Charts Sunday, February 23, 2014 at	chartguy89	02/23/2014 7:17:03 PM
1	PARS Stock Chart 0.0751 Sunday, February 9, 2014	chartguy89	02/09/2014 2:53:58 PM

Recent Articles

• Elevara Medicines Secures Funding to Revolutionize RA Treatment
• Exciting Breakthroughs in Precision Oncology by Onco3R Therapeutics
• Insights into Ringkjøbing Landbobank's Q3 Performance in 2025
• Intellistake Technologies Partners with Mycelium for AI Innovation
• Exploring Wealth Planning: Insights from Andy Garcia's Program
• Understanding the Global Impacts of EU's Circularity Regulation
• Berlin Heals Enhances Leadership with Dr. Eric Fain Addition
• Binance Revolutionizes Banking with Direct USD Transactions
• Global Gastronomy Unveiled at S.Pellegrino Competition Finale
• Discover the Remarkable Features of Huion Kamvas Pro 24 (Gen 3)
• Discover the Groundbreaking Features of Oticon Zeal™ Hearing Aid
• Transforming Pet Healthcare: Rise of Cancer Therapeutics
• Important Transaction Notifications from Company Managers
• Netflix's Leadership Stresses Building Over Buying Amid Merger Talks
• Work Medical Technology Soars 50% After Major Investment Deal
• General Motors Shifts Focus as BrightDrop Van Production Stops
• Raythink Technology Showcases Innovative Thermal Solutions
• LISCure BioSciences Achieves Milestone with Joint Health Probiotic
• Vantaan Energia Optimizes Energy Solutions with Elisa Gridle
• Tesla Analysts Predict Performance Ahead of Q3 Results
• Renalys Pharma Boosts Alport Syndrome Research Endeavors
• Newly Formed Nominating Committee for SciBase's 2026 Meeting
• Sweco's Groundbreaking Infrastructure Project to Control Flooding
• GBI Partners with Nokia for Enhanced Middle East Connectivity
• Hermès Shows Resilience with Steady Growth in Q3 2025
• Innovative Share Buy-Back by NB Private Equity Partners
• Foresight Group's Strategic Share Buyback Program Highlights
• Eurostar Partnering with Alstom for Next-Gen High-Speed Trains
• Solar A/S Strategically Expands with Sonepar Acquisition
• Boliden's Q3 2025: Exceptional Performance Metrics and Insights
• Boliden Q3 2025 Report: Promising Financial Performance
• Transforming Shanghai into a Leading Global Shipping Hub
• LNG2026 Conference: Key Sessions and Influential Speakers
• All Around Polymer Introduces Innovative Nylon Compounding Framework
• Shelf Intelligence: The Retail Revolution Transforming Shopping
• ACM Biolabs Unveils Promising Safety Data for ACM-CpG Therapy
• Bernie Sanders Critiques Jeff Bezos on Job Automation Push
• General Motors Faces EV Market Challenges Amid Industry Changes
• Beneficient Stock Sees Significant Overnight Growth Catalyst
• Sampo plc Announces Significant Share Buybacks for 2025
• Endeavour Mining's Recent Share Buyback Highlights Strategy
• FLSmidth Announces Successful Share Buy-Back Transactions
• Ringkjøbing Landbobank Provides Strong Q3 2025 Update
• Innovative Collaboration Elevates Electric Powertrain Benchmarking
• Promising Results for Novartis' Cosentyx in PMR Treatment
• Novartis Successfully Completes Hart-Scott-Rodino Waiting Period
• BAWAG Group Reports Strong Q3, Exceeding Performance Goals
• Ipsen Expands Oncology Pipeline with ImCheck Acquisition
• Sanofi's Efdoralprin Alfa: A Breakthrough in AATD Treatment
• Heineken N.V.: Navigating Challenges in Q3 Trading Update